Skip to content
Kronox Lab Sciences logo

Kronox Lab Sciences

KRONOX NSE
₹197.29 −0.41 (−0.21%)
P/E
25.59
View as Markdown
MCP
Close 4 Nov 2026 ₹197.29 +51.75 +35.6% 1Y
Start ₹145.54

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
36.00%
Debt to Equity
0.02
EPS (TTM)
₹7.71
Book Value
₹31.30
Market Cap
—
P/E (TTM)
25.59
P/B
6.30
ROE
26.80%
Dividend Yield
0.25%
EBITDA
₹39.50 Cr
52W High
₹227.74
52W Low
₹96.00
Day Range
₹193.25 – ₹203.46
Volume
30,543

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Kronox Lab Sciences peer comparison
Pidilite Industries
₹1,510.2058.04₹1,54,107 Cr13.721.42%23.90%31.00%₹15,399 Cr₹2,677 Cr
Gujarat Fluorochemicals
₹4,613.3083.76₹49,073 Cr6.040.07%7.82%9.64%₹5,303 Cr₹600 Cr
Navin Fluorine International
₹8,785.0057.03₹44,060 Cr10.100.09%19.60%21.00%₹3,634 Cr₹789 Cr
Deepak Nitrite
₹1,578.4027.48₹20,919 Cr3.320.49%9.82%11.40%₹8,575 Cr₹784 Cr
Aether Industries
₹1,540.7086.90₹20,030 Cr7.880.00%9.66%11.90%₹1,231 Cr₹235 Cr
Aarti Industries
₹447.5530.57₹15,838 Cr2.590.23%7.13%6.86%₹9,010 Cr₹531 Cr
Atul
₹5,156.5019.67₹14,827 Cr2.310.59%11.50%14.90%₹6,969 Cr₹788 Cr
Kronox Lab Sciences (this company)
₹197.2925.59₹724 Cr6.300.25%26.80%36.00%₹105 Cr₹29 Cr
Median 8 companies₹1,559.5543.80₹20,474 Cr6.170.24%10.66%13.40%₹6,136 Cr₹692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

57 Good

Data confidence 98/100

surveillance:ESM1

Category scores

Quality
83
Strong
Returns, margins, earnings quality 22% weight
Valuation
33
Poor
Cheap vs sector & own history 24% weight
Growth
40
Weak
Sales & profit trajectory 9% weight
Financial Health
86
Strong
Solvency, leverage, coverage 9% weight
Momentum
87
Strong
Trend strength, vol-adjusted 12% weight
Ownership
68
Strong
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company is almost debt free.
  • Company has delivered good profit growth of 23.2% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 31.4%
  • Company's working capital requirements have reduced from 93.3 days to 71.2 days

Weaknesses

1
  • The company has delivered a poor sales growth of 10.1% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish379
OscillatorsBearish270
Moving AveragesStrong Bullish109

Key readings

RSI (14)
50.95
Neutral
MACD (12,26,9)
−0.14
Bearish
SMA (50)
192.87
Bullish
SMA (200)
150.02
Bullish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+10.25%
3Y+1.71%
1Y+1.00%
TTM+6.07%

Net profit

Net profit growth by window
5Y+22.87%
3Y+20.51%
1Y+12.00%
TTM+11.60%

Operating cash flow

Operating cash flow growth by window
5Y+16.89%
3Y+6.27%
1Y−22.58%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y+9.47 pp
3Y+10.74 pp
1Y+0.66 pp
TTM+0.29 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2020₹50.00 Cr
Mar 2021₹62.00 Cr
Mar 2022₹82.00 Cr
Mar 2023₹96.00 Cr
Mar 2024₹90.00 Cr
Mar 2025₹100 Cr
Mar 2026₹101 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2020₹9.00 Cr
Mar 2021₹10.00 Cr
Mar 2022₹14.00 Cr
Mar 2023₹16.00 Cr
Mar 2024₹21.00 Cr
Mar 2025₹25.00 Cr
Mar 2026₹28.00 Cr

Quarterly Results

₹ Cr
KRONOX quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
25.95
21.02
20.71
22.18
25.19
24.86
24.01
26.13
24.29
25.53
25.27
26.13
28.39
Expenses
17.43
15.16
14.63
14.33
16.98
16.06
15.65
18.38
16.32
16.88
17.24
16.61
19.4
Operating Profit
8.52
5.86
6.08
7.85
8.21
8.8
8.36
7.75
7.97
8.65
8.03
9.52
8.99
OPM %
32.83%
27.88%
29.36%
35.39%
32.59%
35.4%
34.82%
29.66%
32.81%
33.88%
31.78%
36.43%
31.67%
Other Income
0.24
0.49
0.02
0.83
0.43
0.36
0.82
0.91
0.87
1.04
1.13
2.15
1.3
Interest
0
0
0
0
0
0
0
0
0
0.04
0.04
0.04
0.03
Depreciation
0.32
0.38
0.3
0.29
0.33
0.34
0.36
0.35
0.4
0.47
0.52
0.66
0.45
PBT
8.44
5.97
5.8
8.4
8.31
8.82
8.83
8.31
8.44
9.18
8.6
10.97
9.81
Tax %
24.53%
27.14%
18.28%
29.92%
25.99%
26.64%
26.08%
24.07%
25.71%
27.23%
23.37%
26.98%
25.59%
Net Profit
6.38
4.35
4.74
5.88
6.15
6.47
6.53
6.32
6.28
6.68
6.59
8
7.3
EPS (₹)
1.72
1.17
1.28
1.58
1.66
1.74
1.76
1.7
1.69
1.8
1.78
2.16
1.97

Profit & Loss

₹ Cr
KRONOX profit and loss, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
50
62
82
96
90
100
101
105
Expenses
39
48
63
74
62
67
67
70
Operating Profit
12
15
20
22
28
33
34
35
OPM %
23%
24%
24%
23%
32%
33%
34%
33%
Other Income
1
1
1
2
2
3
5
6
Interest
0
0
0
0
0
0
0
0
Depreciation
1
2
2
2
1
1
2
2
PBT
12
13
18
22
29
34
37
39
Tax %
27%
26%
26%
26%
25%
26%
26%
—
Net Profit
9
10
14
16
21
25
28
29
EPS (₹)
Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank.
Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank.
Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank.
4.42
5.75
6.86
7.45
7.71
Div. Payout %
0%
0%
0%
0%
9%
7%
7%
—

Balance Sheet

₹ Cr
KRONOX balance sheet, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.25
0.24
0.24
37
37
37
37
Reserves
23
27
40
8
29
53
79
Borrowings
0
4
3
0
0
0
2
Other Liabilities
11
7
13
9
8
9
10
Total Liabilities
34
38
57
54
74
99
128
Fixed Assets
6
9
11
16
26
28
29
CWIP
0
0
0
0
0
1
1
Investments
0
0
0
0
0
0
0
Other Assets
29
28
45
38
47
70
98
Total Assets
34
38
57
54
74
99
128

Cash Flow

₹ Cr
KRONOX cash flow, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4
11
9
20
17
31
24
Investing
−4
−3
−8
−7
−17
−28
−24
Financing
0
−7
−1
−13
0
−2
0
Net Cash Flow
0
1
1
0
0
0
0
Free Cash Flow
3
10
5
11
5
28
21
CFO/OP
65
100
70
117
87
120
98

Ratios

KRONOX financial ratios, annual
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
110
90
114
71
72
72
76
Inventory Days
70
58
58
61
74
47
66
Days Payable
102
69
89
52
51
54
52
Cash Conversion Cycle
78
79
84
80
94
66
90
Working Capital Days
100
95
122
83
143
65
71
ROCE %
—
50%
51%
50%
52%
44%
36%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Kronox Lab Sciences insights

56 extracted metrics across FY20–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 64.26%
  • Public 28.55%
  • Others 4.55%
  • DIIs 2.54%
  • FIIs 0.10%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Kronox Lab Sciences

What does Kronox Lab Sciences Ltd do?
Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals
Where is Kronox Lab Sciences Ltd (KRONOX) listed?
Kronox Lab Sciences Ltd trades as KRONOX on the NSE and under code 544187 on the BSE.
Which sector does Kronox Lab Sciences Ltd belong to?
Kronox Lab Sciences Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the PE ratio of Kronox Lab Sciences Ltd?
Kronox Lab Sciences Ltd trades at a PE ratio of 25.59 as of 4 Nov 2026, on earnings per share of ₹7.71, against a book value of ₹31.3 per share.
What is the 52-week high and low of Kronox Lab Sciences Ltd?
Over the last 52 weeks Kronox Lab Sciences Ltd has traded between ₹96 and ₹227.74 as of 4 Nov 2026.
Does Kronox Lab Sciences Ltd pay dividends?
Kronox Lab Sciences Ltd has a dividend yield of 0.25%.
What is the Return on Equity (ROE) of Kronox Lab Sciences Ltd?
Kronox Lab Sciences Ltd reported a return on equity of 26.80%. Its debt-to-equity ratio is 0.02.

Company Information

Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals

Website kronoxlabsciences.com
Listed 10 Jun 2024
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/KRONOX.md for Kronox Lab Sciences Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month